September 4, 2024

Opening Bell: Nifty: 25,113.20(-0.66%) Sensex: 82,031.50 (-0.63%) Banknifty : 51,349.40 (-0.66%) Top Gainer: ASIANPAINT, 3,214.25(+1.89%) Top Loser:- ONGC, 754.70(-2.34%) #commodity #StockMarket #FinancialNews #TradingGlobal https://earnfree.in Opening Bell: Nifty: 25,113.20(-0.66%) Sensex: 82,031.50 (-0.63%) Banknifty : 51,349.40 (-0.66%) Top Gainer: ASIANPAINT, 3,214.25(+1.89%) Top Loser:- ONGC, 754.70(-2.34%) #commodity #StockMarket #FinancialNews #TradingGlobal https://earnfree.in

by

Opening Bell:
Nifty: 25,113.20(-0.66%)
Sensex: 82,031.50 (-0.63%)
Banknifty : 51,349.40 (-0.66%)
Top Gainer: ASIANPAINT, 3,214.25(+1.89%)
Top Loser:- ONGC, 754.70(-2.34%) #commodity #StockMarket #FinancialNews #TradingGlobal https://earnfree.in Opening Bell:
Nifty: 25,113.20(-0.66%)
Sensex: 82,031.50 (-0.63%)
Banknifty : 51,349.40 (-0.66%)
Top Gainer: ASIANPAINT, 3,214.25(+1.89%)
Top Loser:- ONGC, 754.70(-2.34%) #commodity #StockMarket #FinancialNews #TradingGlobal https://earnfree.in

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related posts:

No related posts.

Tags:

Comments are closed.

You may also like

July 26, 2024
by

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment...